The Methuselah Foundation held an informal dinner conversation on October 19 to discuss the effort to secure biotechnological strategies for engineered negligible senescence. Questions were fielded by Aubrey de Grey, Chairman and Chief Science Officer of the Methuselah Foundation. Continued from “The Effort to Postpone Frailty Indefinitely“
The Methuselah Foundation held an informal dinner conversation on October 19 to discuss the effort to secure biotechnological strategies for engineered negligible senescence. Questions were fielded by Aubrey de Grey, Chairman and Chief Science Officer of the Methuselah Foundation. Participants included Jeffrey Hall, Executive Director of SENS, and Allison Taguchi, the Development Officer of the Methuselah Foundation. The event itself was organized by Bruce Klein and Susan Fonseca-Klein of the Immortality Institute.